Fresenius, FMC Expect Positive Impact From U.S. Tax Reform
December 27 2017 - 2:16AM
Dow Jones News
By Max Bernhard
Fresenius Medical Care AG & Co. KGaA (FME.XE), or FMC, and
its largest shareholder Fresenius SE & Co. KGaA (FRE.XE) both
expect U.S. tax reform to have a positive impact on 2017 after-tax
earnings, the companies said late Friday.
FMC expects positive effects of around EUR200 million ($237.3
million) on after-tax earnings, while Fresenius said it expects a
one-off gain of around EUR90 million in 2017 group net income. Of
the total, EUR60 million will stem from its holding in FMC, while
EUR30 million would be from Fresenius Kabi, Fresenius said.
The new U.S. tax legislation will come into effect on January 1
and triggers the revaluation of deferred tax liabilities.
Write to Max Bernhard at Max.Bernhard@dowjones.com;
@mxbernhard
(END) Dow Jones Newswires
December 27, 2017 02:01 ET (07:01 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024